Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (221-230 of 263) with videos related to

Pageof 27
Sort By:
Scientific Reports|December 1, 2020
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facilityEnrico Maria Trecarichi, Maria Mazzitelli, Francesca Serapide, et al.
Plos One|July 17, 2010
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeDineke Frentz, Charles A B Boucher, Matthias Assel, et al.
Journal of Infection and Public Health|February 21, 2023
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern ItalySilvio Buscemi, Chiara Davoli, Enrico Maria Trecarichi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failureRaphael Z Sangeda, Kristof Theys, Gertjan Beheydt, et al.
Frontiers in Medicine|March 26, 2024
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumoniaAlessandro Cozzi-Lepri, Vanni Borghi, Salvatore Rotundo, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2016
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimenAndrea De Luca, Philippe Flandre, David Dunn, et al.
International Journal of Epidemiology|April 12, 2012
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration, Charlotte Lewden, Vincent Bouteloup, et al.
Retrovirology|June 26, 2014
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyStefania Bellino, Antonella Tripiciano, Orietta Picconi, et al.
The Lancet. Infectious Diseases|October 13, 2011
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study, , Dominique Costagliola, et al.
Jac-Antimicrobial Resistance|June 20, 2022
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, et al.
Pageof 27

Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
Scientific Reports|December 1, 2020
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facilityEnrico Maria Trecarichi, Maria Mazzitelli, Francesca Serapide, et al.
Plos One|July 17, 2010
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeDineke Frentz, Charles A B Boucher, Matthias Assel, et al.
Journal of Infection and Public Health|February 21, 2023
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern ItalySilvio Buscemi, Chiara Davoli, Enrico Maria Trecarichi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failureRaphael Z Sangeda, Kristof Theys, Gertjan Beheydt, et al.
Frontiers in Medicine|March 26, 2024
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumoniaAlessandro Cozzi-Lepri, Vanni Borghi, Salvatore Rotundo, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2016
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimenAndrea De Luca, Philippe Flandre, David Dunn, et al.
International Journal of Epidemiology|April 12, 2012
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration, Charlotte Lewden, Vincent Bouteloup, et al.
Retrovirology|June 26, 2014
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyStefania Bellino, Antonella Tripiciano, Orietta Picconi, et al.
The Lancet. Infectious Diseases|October 13, 2011
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study, , Dominique Costagliola, et al.
Jac-Antimicrobial Resistance|June 20, 2022
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, et al.
Pageof 27